3Bell WP,Starksen N'F, Tong S,et al. Trousseau' s syndrome: devastating eoagulolopathy in the absence of heparin. Am J Med, 1985;79:423 -430.
4Proctor MC. Indications for filter placement. Semin Vase Surg,2000;13:194- 198.
5Greenfield LJ, Proctor MC: Twenty- year clinical experience with the Greenfield filter. Cardiovas Surg, 1995; 3:199 - 205.
6Levine M , Raskob GE, Landefeld CS, et al. Hemorrhagic complications of anticoagulant treatment. Chest, 1998; 114: 511 - 523.
7Michael B, Streiff. Vena eaval filters: a comprehensive review.Blood. 2000:95:3669--3677.
8Harris EJJ, Kinney EV, Harris EJS, et al. Phlegmasia complicating prophylactic percutaneous inferior vena caval interruption: a word of caution. J Vasv Surg,1995;22:606-611.
9Feinman LJ, Meltzer AJ. Phlegmasia cerulea dolens as a complication of percutaneous insertion of a vena eaval filter. J Am Osteopath Assoc, 1989;89:63--68.
10Matehett WJ, Jones MP, MeFarland DR, et al. Suprarenal vena eaval filter placement : follow - up of four filter types in 22 patients. J Vasc Interv Radiol, 1998;9:588-593.
